New NICE guidance on Lynch syndrome and womb cancer
After a two year engagement process, a new piece of national health guidance, based on research conducted by at The University of Manchester, is set to transform cancer screening practices for thousands of women every year. The research, led by Professor Emma Crosbie, showed that testing women with womb cancer for the genetic condition Lynch syndrome, will save lives by identifying family members who share a heightened cancer risk. After raising awareness of this work with the #LetsTalkLynch campaign in 2018, the research team worked with the National Institute of Health and Care Excellence (NICE) to make the case for wider Lynch syndrome testing. On Wednesday, 28 October 2020, NICE published their official guidance calling for all women with womb cancer to be tested for Lynch syndrome. When fully implemented, this guideline will mean an additional 1,000 people per year can be put into surveillance programmes that will reduce their risk of cancer and detect cancers earlier – meaning a huge leap forward in survivability and life expectancy. More info: https://www.policy.manchester.....ac.uk/activities/lyn
-
Category
No comments found